The pathology was microinvasive lobular carcinoma, arising in a background of multifocal lobular carcinoma in situ (LCIS), ER- (0%), PR - (0%), HER-2 negative (1+), Ki-67 10–15%. This evidence concerns the gene ERBB2 and breast carcinoma.